)
SELLAS Life Sciences Group (SLS) investor relations material
SELLAS Life Sciences Group Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 16, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by June 15, 2026.
Voting matters and shareholder proposals
Election of two Class I directors for a three-year term expiring at the 2029 annual meeting.
Ratification of Baker Tilly US, LLP as independent auditor for fiscal year ending December 31, 2026.
Approval to amend the 2023 Equity Incentive Plan to increase authorized shares by 20,000,000.
Advisory approval of executive compensation (say-on-pay) for named executive officers.
Approval for potential postponement or adjournment of the annual meeting to solicit additional proxies or establish a quorum.
Board of directors and corporate governance
Nominees for Class I director positions are Robert Van Nostrand and Jane Wasman.
- Annual meeting to vote on directors, auditor, equity plan, executive pay, and governance matters.SLS
Proxy filing23 Apr 2026 - Strong cash position and clinical progress in AML set stage for pivotal 2026.SLS
Q4 202519 Mar 2026 - REGAL Phase 3 interim analysis in AML will guide next steps after IDMC review in January 2025.SLS
Study Update11 Jan 2026 - Late-stage cancer drug developer registers resale of 19.7M shares tied to new warrant inducement.SLS
Registration Filing16 Dec 2025 - Six key proposals, including director elections and compensation, headline the 2025 virtual meeting.SLS
Proxy Filing2 Dec 2025 - Key votes include director elections, auditor ratification, and ESPP share increase.SLS
Proxy Filing2 Dec 2025 - Auditor change to Baker Tilly for 2025; prior votes valid, no new proxy cards needed.SLS
Proxy Filing2 Dec 2025 - Net loss narrowed, cash reserves grew, and key oncology trials advanced amid ongoing risks.SLS
Q3 202512 Nov 2025 - GPS and SLS009 advance as differentiated AML therapies, supported by strong data and financing.SLS
R&D Day 20255 Nov 2025
Next SELLAS Life Sciences Group earnings date
Next SELLAS Life Sciences Group earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage